Xenofon Baraliakos

Summary

Country: Germany

Publications

  1. ncbi Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Arthritis Res Ther 7:R439-44. 2005
  2. ncbi The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Landgrafenstr, 15, 44652 Herne, Germany
    Arthritis Res Ther 10:R104. 2008
  3. ncbi Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne Ruhr University, Bochum, Germany
    J Rheumatol 34:510-5. 2007
  4. ncbi Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Uta Kiltz
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Arthritis Care Res (Hoboken) 64:1415-22. 2012
  5. ncbi The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Curr Rheumatol Rep 13:383-7. 2011
  6. ncbi Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Rheumatology (Oxford) 50:1690-9. 2011
  7. ncbi Anti-TNF-alpha therapy with infliximab in spondyloarthritides
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Landgrafenstr 15, 44652 Herne, Germany
    Expert Rev Clin Immunol 6:9-19. 2010
  8. ncbi Treatment of ankylosing spondylitis and other spondyloarthritides
    Juergen Braun
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Curr Opin Rheumatol 21:324-34. 2009
  9. ncbi OMERACT magnetic resonance imaging initiative on structural and inflammatory lesions in ankylosing spondylitis--report of a special interest group at OMERACT 10 on sacroiliac joint and spine lesions
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Landgrafenstr 15, 44652 Herne, Germany
    J Rheumatol 38:2051-4. 2011
  10. ncbi Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
    Jurgen Braun
    Rheumazentrum Ruhrgebiet, Herne, Ruhr University, Bochum, Germany
    Ann Rheum Dis 71:878-84. 2012

Collaborators

Detail Information

Publications17

  1. ncbi Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Arthritis Res Ther 7:R439-44. 2005
    ..Discontinuation of long-term therapy with infliximab eventually led to relapse of disease activity in all patients but one...
  2. ncbi The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Landgrafenstr, 15, 44652 Herne, Germany
    Arthritis Res Ther 10:R104. 2008
    ..Whether and how spondylitis and syndesmophyte formation are linked are unclear. Our objective was to investigate whether and how spinal inflammation are associated with new bone formation in ankylosing spondylitis...
  3. ncbi Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne Ruhr University, Bochum, Germany
    J Rheumatol 34:510-5. 2007
    ....
  4. ncbi Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Uta Kiltz
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Arthritis Care Res (Hoboken) 64:1415-22. 2012
    ..The differentiating features are incompletely understood...
  5. ncbi The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Curr Rheumatol Rep 13:383-7. 2011
    ..Female AS patients showed more cervical structural lesions, but male patients overall showed more rapid progress, leading us to conclude that dorsal vertebral edges do not add in depiction of radiographic deterioration in AS patients...
  6. ncbi Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Rheumatology (Oxford) 50:1690-9. 2011
    ..To report for the first time on the efficacy and safety of anti-TNF therapy after 8 years of follow-up in patients with active AS, and analyse possible short-term predictors for long-term clinical outcomes...
  7. ncbi Anti-TNF-alpha therapy with infliximab in spondyloarthritides
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Landgrafenstr 15, 44652 Herne, Germany
    Expert Rev Clin Immunol 6:9-19. 2010
    ..Serious adverse events on anti-TNF therapy have remained rare as these can be largely prevented by appropriate screening. The large benefits of anti-TNF therapy in AS seem to outweigh the few shortcomings of this treatment...
  8. ncbi Treatment of ankylosing spondylitis and other spondyloarthritides
    Juergen Braun
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Curr Opin Rheumatol 21:324-34. 2009
    ..The purpose of this review was to collect all available information related to the treatment of ankylosing spondylitis published in the year 2008. This was achieved by a systematic literature search in PubMed...
  9. ncbi OMERACT magnetic resonance imaging initiative on structural and inflammatory lesions in ankylosing spondylitis--report of a special interest group at OMERACT 10 on sacroiliac joint and spine lesions
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Landgrafenstr 15, 44652 Herne, Germany
    J Rheumatol 38:2051-4. 2011
    ....
  10. ncbi Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
    Jurgen Braun
    Rheumazentrum Ruhrgebiet, Herne, Ruhr University, Bochum, Germany
    Ann Rheum Dis 71:878-84. 2012
    ..To evaluate golimumab's effect on MRI-detected spinal inflammation in ankylosing spondylitis (AS)...
  11. ncbi The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Herne, Germany
    J Rheumatol 36:997-1002. 2009
    ..To describe the natural course of radiographic progression and to differentiate rates of progression in patients with ankylosing spondylitis (AS)...
  12. ncbi Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Rheumatology (Oxford) 51:1378-87. 2012
    ..To perform a literature review as basis for the update of the Assessment in SpondyloArthritis international Society/European League Against Rheumatism (ASAS/EULAR) treatment recommendations with biologics in AS...
  13. ncbi Imaging in axial spondyloarthritis: diagnostic problems and pitfalls
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Rheum Dis Clin North Am 38:513-22. 2012
    ..Diagnosis of SpA should result from the combination of clinical, laboratory and imaging findings...
  14. ncbi Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?
    Uta Kiltz
    Rheumazentrum Ruhrgebiet, St Josefs Krankenhaus, Landgrafenstr 15, 44652 Herne, Germany
    Curr Opin Rheumatol 24:252-60. 2012
    ..A variety of new drug classes have been investigated during the last years for the treatment of patients with AS in whom TNF blockers have failed or are contraindicated...
  15. ncbi Biologic therapies for spondyloarthritis: what is new?
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Landgrafenstr 15, 44652 Herne, Germany
    Curr Rheumatol Rep 14:422-7. 2012
    ..The anti-IL-17a antibody secukinumab may be efficacious, on the basis of a proof-of-concept trial. Finally, first data on biosimilars of TNF blockers have recently been presented...
  16. ncbi Spondyloarthritides
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany
    Best Pract Res Clin Rheumatol 25:825-42. 2011
    ..As far as it stands now, TNF blockers seem to have no influence on new bone formation in AS...
  17. ncbi Microsurgical nerve root decompression in scoliotic lumbar spines-the relationship between important anatomical structures in correlation to imaging and implications for daily practice: anatomic cadaveric study
    Amar Ali
    Institute for Spine Research, Ruhr University Bochum, Bochum, Germany
    J Neurosurg Spine 13:123-32. 2010
    ..These results confirm a topographic anatomical discrepancy. This knowledge can be used in daily perioperative practice for patients undergoing microsurgical decompression...